Technology Transfer Center

The National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), is committed to forging scientific partnerships with industry, academia and nonprofit organizations to accelerate the pace of medical research and the application of that knowledge to improve the Nation’s health.

These scientific partnerships benefit the NIH laboratories and the partnering outside organizations by making personnel, services, facilities, expertise, material, and equipment accessible to both partners.

The Technology Transfer Center merges scientific inquiry with commercial development through services including:

• Transactional Agreements

  • Material Transfer Agreements (MTA)
  • Confidential Disclosure Agreements (CDA)
  • Collaboration Agreements (C-MTA)
  • Clinical Trial Agreements (CTA)
  • Cooperative Research and Development (CRADA)

• Marketing and promoting technology

  • NIH technologies available for collaboration and licensing (TTC website)
  • NIH licensees and NIH SBIR/STTR awardees can showcase technology on the NIH Office of Technology Transfer’s Pipeline to Partnerships website http://ott.od.nih.gov/p2p/index.aspx
• Intellectual property advice to NIH investigators to maintain the commercial viability of NIH technologies

To learn more about technology transfer at the Frederick National Lab contact the staff at:

Technology Transfer Center
Frederick National Laboratory for Cancer Research
ATRF, Room E3202
8560 Progress Drive
Frederick, MD 21701
Phone: 301-846-5465

Email: higinbok@mail.nih.gov

See also: TTC website at NIH, http://ttc.nci.nih.gov